| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/02/1999 | CA2322003A1 Human monoclonal antibodies capable of oligospecifically recognizing the major tumor-associated gangliosides and methods of use thereof |
| 09/02/1999 | CA2321993A1 Therapeutic blockade of icer synthesis to prevent icer-mediated inhibition of immune cell activity |
| 09/02/1999 | CA2321974A1 Tumor associated antigen 791tgp72 |
| 09/02/1999 | CA2321970A1 36 human secreted proteins |
| 09/02/1999 | CA2321950A1 Cultivar specificity gene from the rice pathogen magnaporthe grisea, and methods of use |
| 09/02/1999 | CA2321947A1 High affinity humanized anti-cea monoclonal antibodies |
| 09/02/1999 | CA2321946A1 Methods and compositions using tumor specific soluble interleukin-2 receptor alpha molecules |
| 09/02/1999 | CA2321932A1 High affinity humanized anti-tag-72 monoclonal antibodies |
| 09/02/1999 | CA2321883A1 Isolated stromal cells for use in the treatment of diseases of the central nervous system |
| 09/02/1999 | CA2321870A1 Cell cycle related proteins |
| 09/02/1999 | CA2321869A1 Human proteinase molecules |
| 09/02/1999 | CA2321747A1 Human smn-like protein |
| 09/02/1999 | CA2321746A1 Human protein kinase c inhibitor |
| 09/02/1999 | CA2321667A1 Human channel-related molecules |
| 09/02/1999 | CA2321223A1 Hla linked pre-eclampsia and miscarriage susceptibility gene |
| 09/02/1999 | CA2321200A1 Composition for transporting negatively charged substances |
| 09/02/1999 | CA2321195A1 Monoclonal antibody for immunologically analyzing or concentrating endocrine disruptor or its degradation product and utilization of the same |
| 09/02/1999 | CA2321178A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 09/02/1999 | CA2321142A1 Protease-activated receptor 4 and uses thereof |
| 09/02/1999 | CA2321129A1 Best's macular dystrophy gene |
| 09/02/1999 | CA2321098A1 Photoactivatable nucleic acid derivatives |
| 09/02/1999 | CA2320894A1 Protein interaction and transcription factor trap |
| 09/02/1999 | CA2320403A1 Enhancing the circulating half-life of antibody-based fusion proteins |
| 09/02/1999 | CA2315549A1 Family of maize pr-1 genes and promoters |
| 09/02/1999 | CA2288219A1 Novel dna fragment directing gene expression predominant in flower organ |
| 09/02/1999 | CA2287878A1 Diagnostic method and kit for neuropsychiatric diseases using trinucleotide repeats sequence |
| 09/02/1999 | CA2287226A1 Human c-maf compositions and methods of use thereof |
| 09/01/1999 | EP0939136A1 Assay for predicting the angiographic response to lipid-lowering therapy in patients |
| 09/01/1999 | EP0939131A2 Aminopeptidases |
| 09/01/1999 | EP0939130A1 Rna polymerase |
| 09/01/1999 | EP0939128A2 New HCV isolates |
| 09/01/1999 | EP0939127A2 Humanized immunoglobulins and their production and use |
| 09/01/1999 | EP0939126A1 Tumor suppressor gene Del-27 and the protein coded thereby, methods of production and use thereof |
| 09/01/1999 | EP0939125A2 Expression vector for the conditional regulation of expression of the large subunit of polymerase II |
| 09/01/1999 | EP0939124A2 MGBP1 sequences |
| 09/01/1999 | EP0939123A2 Estrogen receptor-related polypetide SBPERR4 |
| 09/01/1999 | EP0939122A1 Mouse TCF-3 and TCF-4 and tumorigenesis related to WNT/Wingless signalling |
| 09/01/1999 | EP0939121A2 TNF-binding proteins |
| 09/01/1999 | EP0939120A1 Method for marker-free repetitive DNA expression cassette exchange in the genome of cells or parts of cells |
| 09/01/1999 | EP0939119A1 Transmembrane trapping methods |
| 09/01/1999 | EP0938904A1 Mammalian cell transduction for use in gene therapy |
| 09/01/1999 | EP0938679A2 Receptor binding assay, appropriate recombinant fusion receptor for said assay, vector for its production and reagent kit for implementing the receptor binding assay |
| 09/01/1999 | EP0938589A1 Method of identifying pharmaceuticals from plant extracts |
| 09/01/1999 | EP0938588A2 Signal amplification method |
| 09/01/1999 | EP0938584A2 Method of preparing (s) - or (r) -3,3,3-trifluoro-2-hydroxy-2- methylpropionic acid |
| 09/01/1999 | EP0938583A1 Dna purification procedure |
| 09/01/1999 | EP0938579A1 Improved adenovirus vectors generated from helper viruses and helper-dependent vectors |
| 09/01/1999 | EP0938578A1 Genetic modification of primate hemopoietic repopulating stem cells |
| 09/01/1999 | EP0938577A2 Method for genetic control of seed maturation |
| 09/01/1999 | EP0938575A1 Zearalenone detoxification compositions and methods |
| 09/01/1999 | EP0938574A1 Method for inducing viral resistance into a plant |
| 09/01/1999 | EP0938573A2 Plant cellulose synthase and promoter sequences |
| 09/01/1999 | EP0938572A1 Promoter from tobacco |
| 09/01/1999 | EP0938571A1 Method for the oligomerisation of peptides |
| 09/01/1999 | EP0938570A1 MUTANT $g(a)-AMYLASE COMPRISING MODIFICATION AT RESIDUES CORRESPONDING TO A210, H405 AND/OR T412 IN $i(BACILLUS LICHENIFORMIS) |
| 09/01/1999 | EP0938569A1 Leaf-specific gene expression in transgenetic plants |
| 09/01/1999 | EP0938568A1 Plant phytases and biotechnological applications |
| 09/01/1999 | EP0938567A1 Applications for regulatory region of nos isoforms |
| 09/01/1999 | EP0938565A2 Vaccine compositions |
| 09/01/1999 | EP0938564A1 Disease resistance in vitis |
| 09/01/1999 | EP0938563A1 Use of herpes simplex virus orf p protein in repression of viral protein synthesis and related methods |
| 09/01/1999 | EP0938562A2 Pesticidal toxins and nucleotide sequences which encode these toxins |
| 09/01/1999 | EP0938561A1 Genes encoding mycobacterial proteins associated with cell binding and cell entry and uses thereof |
| 09/01/1999 | EP0938560A1 GENOMIC NUCLEIC ACIDS, cDNA AND mRNA WHICH CODE FOR POLYPEPTIDES WITH IL-16 ACTIVITY, PROCESSES FOR THE PRODUCTION THEREOF AND THEIR USE |
| 09/01/1999 | EP0938559A2 HUMAN POLYHOMEOTIC 2 (hph2) ACTS AS A TUMOR SUPPRESSOR |
| 09/01/1999 | EP0938558A2 Gaba a receptor subunit epsilon-related protein |
| 09/01/1999 | EP0938557A2 Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian cd97 alpha subunit |
| 09/01/1999 | EP0938556A1 Gamma-heregulin |
| 09/01/1999 | EP0938555A1 Constructs and complexes of cyclin e |
| 09/01/1999 | EP0938554A1 Human protein kinase c inhibitor homolog |
| 09/01/1999 | EP0938553A1 Dna encoding dp. 75 and a process for its use |
| 09/01/1999 | EP0938552A1 Site-specific mutagenesis and mutant selection utilizing antibiotic-resistant markers encoding gene products having altered substrate specificity |
| 09/01/1999 | EP0938551A1 Ku DEFICIENT CELLS AND NON-HUMAN TRANSGENIC ANIMALS |
| 09/01/1999 | EP0938550A1 Cultured inner cell mass cell lines derived from ungulate embryos |
| 09/01/1999 | EP0938548A1 Isolated tumor necrosis factor receptor releasing enzyme, compositions comprising the enzyme and methods of the use thereof |
| 09/01/1999 | EP0938547A1 Modified ligands of calcium-dependent binding proteins |
| 09/01/1999 | EP0938546A1 Hppd gene and inhibitors |
| 09/01/1999 | EP0938545A1 Novel methods and compositions for combinatorial-based discovery of new multimeric molecules |
| 09/01/1999 | EP0938506A1 Immunoglobulin superfamily domains and fragments with increased solubility |
| 09/01/1999 | EP0938505A1 Anti-endoglin monoclonal antibodies and their use in antiangiogenic therapy |
| 09/01/1999 | EP0938501A1 Process for the purification of human interleukin-1 receptor antagonist from recombinant e. coli |
| 09/01/1999 | EP0938381A1 Sample collection devices and methods using markers and the use of such markers as controls in sample validation, laboratory evaluation and/or accreditation |
| 09/01/1999 | EP0938337A1 Chimeric kanamycin resistance gene |
| 09/01/1999 | EP0938334A1 Improved method of treating immune cell mediated systemic diseases |
| 09/01/1999 | EP0938298A1 Liposomes |
| 09/01/1999 | EP0815121A4 Modified-affinity streptavidin |
| 09/01/1999 | EP0805873B1 Methods for sensitive detection of reverse transcriptase |
| 09/01/1999 | EP0770143A4 Method to identify tumor suppressor genes |
| 09/01/1999 | EP0765335B1 Universal process for isolating and purifying nucleic acids from extremely small amounts of highly contaminated various starting materials |
| 09/01/1999 | EP0764218A4 Method of detecting cellular material |
| 09/01/1999 | EP0752882A4 Treatment for juvenile diabetes |
| 09/01/1999 | EP0725833A4 Prenatal diagnosis by isolation of fetal granulocytes from maternal blood |
| 09/01/1999 | EP0723455A4 Methods of inhibiting phagocytosis |
| 09/01/1999 | EP0701616B1 Multicistronic expression of recombinant genes in bacterial cells |
| 09/01/1999 | EP0652951B1 GDF-1and UOG-1 proteins |
| 09/01/1999 | EP0625160B1 Leukinferon preparation |
| 09/01/1999 | EP0618983B1 Insertion elements and amplifiable nucleic acids |
| 09/01/1999 | EP0573545B1 Monoclonal antibodies against receptor-induced binding sites |
| 09/01/1999 | EP0553186B1 Method for producing t h?-independent cytotoxic t lymphocytes |
| 09/01/1999 | EP0542833B1 Insecticidal proteins |